MedTrace Logo

The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy

NCT02135679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2024-11-20

Study results available
· View outcomes & findings →

Summary

CTC levels collected pre-surgery will be correlated with pathological samples.

Conditions

Interventions

RADIATION

Radiotherapy

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Steven Feigenberg, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2019-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02135679 on ClinicalTrials.gov